On Monday, Tharimmune Inc (NASDAQ: THAR) opened lower -3.55% from the last session, before settling in for the closing price of $1.41. Price fluctuations for THAR have ranged from $1.28 to $7.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 42.15% at the time writing. With a float of $2.07 million, this company’s outstanding shares have now reached $2.11 million.
Let’s look at the performance matrix of the company that is accounted for 2 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tharimmune Inc (THAR) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tharimmune Inc is 1.62%, while institutional ownership is 7.07%. The most recent insider transaction that took place on Dec 19 ’24, was worth 9,752. In this transaction CEO of this company bought 4,600 shares at a rate of $2.12, taking the stock ownership to the 17,534 shares. Before that another transaction happened on Nov 13 ’24, when Company’s Chief Operating Officer bought 5,000 for $2.02, making the entire transaction worth $10,096. This insider now owns 10,758 shares in total.
Tharimmune Inc (THAR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.15% per share during the next fiscal year.
Tharimmune Inc (NASDAQ: THAR) Trading Performance Indicators
Check out the current performance indicators for Tharimmune Inc (THAR). In the past quarter, the stock posted a quick ratio of 1.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.68, a number that is poised to hit -0.84 in the next quarter
Technical Analysis of Tharimmune Inc (THAR)
Tharimmune Inc (NASDAQ: THAR) saw its 5-day average volume 0.22 million, a positive change from its year-to-date volume of 79467.0. As of the previous 9 days, the stock’s Stochastic %D was 22.68%. Additionally, its Average True Range was 0.16.
During the past 100 days, Tharimmune Inc’s (THAR) raw stochastic average was set at 8.59%, which indicates a significant decrease from 32.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.58% in the past 14 days, which was lower than the 72.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7130, while its 200-day Moving Average is $2.4313. Nevertheless, the first resistance level for the watch stands at $1.6067 in the near term. At $1.8533, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0567. If the price goes on to break the first support level at $1.1567, it is likely to go to the next support level at $0.9533. Assuming the price breaks the second support level, the third support level stands at $0.7067.
Tharimmune Inc (NASDAQ: THAR) Key Stats
There are currently 2,109K shares outstanding in the company with a market cap of 2.87 million. Presently, the company’s annual sales total 0 K according to its annual income of -9,320 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,800 K.
